115. Hereditary periodic paralysis Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 2 Drugs : 3 - (DrugBank : 3) / Drug target genes : 18 - Drug target pathways : 9

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Acetazolamide
   University of Rochester
      2008   Phase 1   NCT00839501   United Kingdom;United States
Flecainide + BETA-blocker
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2025   Phase 2   NCT06205550   -
Potassium
   University of Rochester
      2008   Phase 1   NCT00839501   United Kingdom;United States